Epithelioid angiosarcomas of the aorta are extremely rare neoplasms with only 26 previous reports in the literature. An extremely unusual case is reported of an aortic epithelioid angiosarcoma diagnosed in a 47-year-old man who was being evaluated for his rectal adenocarcinoma. This case prompted a review of literature for aortic intimal neoplasms. No previous reports of a synchronous aortic angiosarcomas and adenocarcinomas of the colorectum have been reported. Even though the occurrence of the aortic intimal neoplasia and rectal cancer in this patient is most likely coincidental, the onset of this disease in a young man without risk factors for either disease probably suggests a genetic basis of his disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsurg.2007.01.025DOI Listing

Publication Analysis

Top Keywords

epithelioid angiosarcoma
8
47-year-old man
8
neoplasms previous
8
previous reports
8
aortic intimal
8
angiosarcoma aorta
4
aorta 47-year-old
4
man case
4
case report
4
report literature
4

Similar Publications

Angiosarcoma is a rare and aggressive malignant tumor arising from vascular or lymphatic endothelial cells. Angiosarcoma at an arteriovenous fistula site is exceptionally rare. We report a case of a 37-year-old male renal transplant recipient who developed a high-grade epithelioid angiosarcoma at the site of an arteriovenous fistula six years post-transplant.

View Article and Find Full Text PDF

There has been noteworthy progress in molecular characterisation and therapeutics in soft tissue sarcomas. Novel agents have gained regulatory approval by the FDA. Examples are the tyrosine kinase inhibitors avapritinib and ripretinib in gastrointestinal stromal tumours (GIST), the immune check point inhibitor atezolizumab in alveolar soft part tissue sarcoma, the γ-secretase inhibitor nirogacestat in desmoid tumours, the NTRK inhibitors larotrectinib and entrectinib in tumours with fusions, the mTOR inhibitor nab-sirolimus in PEComa, and the EZH-2 inhibitor tazemetostat in epithelioid sarcoma.

View Article and Find Full Text PDF

Angiosarcomas are a type of malignant tumor of vascular origin. They represent <1% of all primary bone tumors. The multicentric or metastatic does not differ in its high aggressiveness and poor prognosis.

View Article and Find Full Text PDF

Sarcomas are a rare type of malignancy with limited treatment options so far. This analysis aimed to describe the impact of lymphadenectomy on treating sarcoma patients. Sarcomas characterized by lymphatic spread are rare.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!